BGI is a genomics research and development institution, which was established in August 2008 and headquartered in Shenzhen, China. Its founder is Wang Jian. 201July 14, Huada Gene was listed on Shenzhen Stock Exchange; The main shareholders are Shenzhen Huada Gene Technology Co., Ltd., Shenzhen Qianhai Huada Gene Investment Enterprise (Limited Partnership) and Shenzhen Heyu Gaolin Equity Investment Partnership (Limited Partnership); Companies that compete with BGI to varying degrees in China and around the world include Kaituo Pharmaceutical -B, Chengdu Pioneer, ApreaTherapeutics, BridgeBioPharma, etc.
More peer analysis, the company knows and understands.